Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Compensated Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableNot Yet RecruitingNCT07777198
What this trial is testing

Liver Stiffness Changes by iLivTouch to Predict Liver-Related Events in MAFLD

Who this might be right for
MAFLD
Beijing Friendship Hospital 2,303
Not applicableStudy completedNCT02508298
What this trial is testing

Surrogate Markers of Portal Pressure

Who this might be right for
Portal HypertensionCirrhosis
VA Connecticut Healthcare System 41
Testing effectiveness (Phase 2)Study completedNCT00230503
What this trial is testing

Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Bausch Health Americas, Inc. 220
Post-approval studies (Phase 4)Study completedNCT00646503
What this trial is testing

Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Novartis 150
Large-scale testing (Phase 3)Ended earlyNCT00811967
What this trial is testing

Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)

Who this might be right for
Hepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 50
Testing effectiveness (Phase 2)Study completedNCT00804622
What this trial is testing

Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)

Who this might be right for
Chronic Hepatitis B
The University of Hong Kong 15
Large-scale testing (Phase 3)Study completedNCT00687219
What this trial is testing

Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)

Who this might be right for
Hepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 102
Large-scale testing (Phase 3)Study completedNCT02207088
What this trial is testing

Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease

Who this might be right for
Chronic Hepatitis CHepatitis C VirusCompensated Cirrhosis+2 more
AbbVie 68
Post-approval studies (Phase 4)Study completedNCT00537537
What this trial is testing

To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B, Chronic
Novartis Pharmaceuticals 100
Not applicableUnknownNCT04646928
What this trial is testing

Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
CHA University 245
Post-approval studies (Phase 4)UnknownNCT03037151
What this trial is testing

Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV

Who this might be right for
Compensated Cirrhosis
The HIV Netherlands Australia Thailand Research Collaboration 100